This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
It has been two years since the introduction of tolbutamide (Orinase) in the United States. Many of us have had excellent results from its use. All observers agree that it is effective in the obese, elderly patient with mild diabetes and that it is a valuable contribution in the treatment of diabetes mellitus, points which were well covered in the excellent editorial that appeared in the June 1, 1957, issue of The Journal. However, I feel that a completely incorrect impression that the orally given hypoglycemic agents are insulin substitutes is created by such articles as "Clinical Use of Tolbutamide (Orinase) in Office and Home Care of Diabetics" in the June 8, 1957, issue of The Journal. I must express my objection especially to the statement, "No longer do their [diabetics'] lives depend upon a refrigerator's proximity—a liberation of marked psychological importance." Furthermore, 45 cases is a
Felder L. TREATMENT FOR DIABETES MELLITUS. JAMA. 1957;164(13):1504–1505. doi:10.1001/jama.1957.02980130080022
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: